APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human BMP-2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Recombinant Human BMP-2 Market Outlook and Growth Opportunities 2026

Report ID 174031460426 December 2025205 pages

Choose your research edition.

Industry ResearchRecombinant Human BMP-2 Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human BMP-2 Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Recombinant Human BMP-2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human BMP-2 Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human BMP-2 Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Recombinant Human BMP-2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Recombinant Human BMP-2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Human BMP-2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human BMP-2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Recombinant Human BMP-2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Recombinant Human BMP-2 market include 赛默飞世尔, Yeasen Biotechnology (Shanghai), Yantai Zhenghai Bio-Tech, Abbkine Scientific, WEIGAO, Shanghai Zhong Qiao Xin Zhou Biotechnology, Shanghai NovoPro, HANGZHOU JIUYUAN GENE ENGINEERIN and Beijing Baiaolaibo Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Recombinant Human BMP-2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Human BMP-2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Human BMP-2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Recombinant Human BMP-2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Recombinant Human BMP-2 Segment by Company

赛默飞世尔

Yeasen Biotechnology (Shanghai)

Yantai Zhenghai Bio-Tech

Abbkine Scientific

WEIGAO

Shanghai Zhong Qiao Xin Zhou Biotechnology

Shanghai NovoPro

HANGZHOU JIUYUAN GENE ENGINEERIN

Beijing Baiaolaibo Technology

STEMCELL Technologies

Sigma Aldrich

Proteintech

CUSABIO TECHNOLOGY

Cgbio

Cell Guidance Systems

Biomol GmbH

Recombinant Human BMP-2 Segment by Type

Powder

Sponge

Others

Recombinant Human BMP-2 Segment by Application

Hospital

Research Institute

Others

Recombinant Human BMP-2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Recombinant Human BMP-2 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Recombinant Human BMP-2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Recombinant Human BMP-2 significant trends, drivers, influence factors in global and regions.

6. To analyze Recombinant Human BMP-2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human BMP-2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human BMP-2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human BMP-2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Recombinant Human BMP-2 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Recombinant Human BMP-2 industry.

Chapter 3: Detailed analysis of Recombinant Human BMP-2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Recombinant Human BMP-2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Recombinant Human BMP-2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Recombinant Human BMP-2 Industry Trends Table 2. Recombinant Human BMP-2 Industry Drivers Table 3. Recombinant Human BMP-2 Industry Opportunities and Challenges Table 4. Recombinant Human BMP-2 Industry Restraints Table 5. Global Recombinant Human BMP-2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Recombinant Human BMP-2 Revenue Share by Company (2021-2026) Table 7. Global Recombinant Human BMP-2 Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Recombinant Human BMP-2 Sales Volume Share by Company (2021-2026) Table 9. Global Recombinant Human BMP-2 Average Price (US$/g) of Company (2021-2026) Table 10. Global Recombinant Human BMP-2 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Recombinant Human BMP-2 Key Company Manufacturing Base & Headquarters Table 12. Global Recombinant Human BMP-2 Company, Product Type & Application Table 13. Global Recombinant Human BMP-2 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Recombinant Human BMP-2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Powder Table 18. Significant Companies of Sponge Table 19. Significant Companies of Others Table 20. Global Recombinant Human BMP-2 Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 21. Global Recombinant Human BMP-2 Sales Volume by Type (2021-2026) & (Kg) Table 22. Global Recombinant Human BMP-2 Sales Volume by Type (2027-2032) & (Kg) Table 23. Global Recombinant Human BMP-2 Sales Volume Share by Type (2021-2026) Table 24. Global Recombinant Human BMP-2 Sales Volume Share by Type (2027-2032) Table 25. Global Recombinant Human BMP-2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Recombinant Human BMP-2 Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Recombinant Human BMP-2 Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Recombinant Human BMP-2 Sales Value Share by Type (2021-2026) Table 29. Global Recombinant Human BMP-2 Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Research Institute Table 32. Significant Companies of Others Table 33. Global Recombinant Human BMP-2 Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 34. Global Recombinant Human BMP-2 Sales Volume by Application (2021-2026) & (Kg) Table 35. Global Recombinant Human BMP-2 Sales Volume by Application (2027-2032) & (Kg) Table 36. Global Recombinant Human BMP-2 Sales Volume Share by Application (2021-2026) Table 37. Global Recombinant Human BMP-2 Sales Volume Share by Application (2027-2032) Table 38. Global Recombinant Human BMP-2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Recombinant Human BMP-2 Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Recombinant Human BMP-2 Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Recombinant Human BMP-2 Sales Value Share by Application (2021-2026) Table 42. Global Recombinant Human BMP-2 Sales Value Share by Application (2027-2032) Table 43. Global Recombinant Human BMP-2 Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 44. Global Recombinant Human BMP-2 Sales by Region (2021-2026) & (Kg) Table 45. Global Recombinant Human BMP-2 Sales Market Share by Region (2021-2026) Table 46. Global Recombinant Human BMP-2 Sales by Region (2027-2032) & (Kg) Table 47. Global Recombinant Human BMP-2 Sales Market Share by Region (2027-2032) Table 48. Global Recombinant Human BMP-2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Recombinant Human BMP-2 Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Recombinant Human BMP-2 Sales Value Share by Region (2021-2026) Table 51. Global Recombinant Human BMP-2 Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Recombinant Human BMP-2 Sales Value Share by Region (2027-2032) Table 53. Global Recombinant Human BMP-2 Market Average Price (US$/g) by Region (2021-2026) Table 54. Global Recombinant Human BMP-2 Market Average Price (US$/g) by Region (2027-2032) Table 55. Global Recombinant Human BMP-2 Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Global Recombinant Human BMP-2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Recombinant Human BMP-2 Sales by Country (2021-2026) & (Kg) Table 58. Global Recombinant Human BMP-2 Sales Market Share by Country (2021-2026) Table 59. Global Recombinant Human BMP-2 Sales by Country (2027-2032) & (Kg) Table 60. Global Recombinant Human BMP-2 Sales Market Share by Country (2027-2032) Table 61. Global Recombinant Human BMP-2 Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Recombinant Human BMP-2 Sales Value Market Share by Country (2021-2026) Table 63. Global Recombinant Human BMP-2 Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Recombinant Human BMP-2 Sales Value Market Share by Country (2027-2032) Table 65. 赛默飞世尔 Company Information Table 66. 赛默飞世尔 Business Overview Table 67. 赛默飞世尔 Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 68. 赛默飞世尔 Recombinant Human BMP-2 Product Portfolio Table 69. 赛默飞世尔 Recent Development Table 70. Yeasen Biotechnology (Shanghai) Company Information Table 71. Yeasen Biotechnology (Shanghai) Business Overview Table 72. Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 73. Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Product Portfolio Table 74. Yeasen Biotechnology (Shanghai) Recent Development Table 75. Yantai Zhenghai Bio-Tech Company Information Table 76. Yantai Zhenghai Bio-Tech Business Overview Table 77. Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 78. Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Product Portfolio Table 79. Yantai Zhenghai Bio-Tech Recent Development Table 80. Abbkine Scientific Company Information Table 81. Abbkine Scientific Business Overview Table 82. Abbkine Scientific Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 83. Abbkine Scientific Recombinant Human BMP-2 Product Portfolio Table 84. Abbkine Scientific Recent Development Table 85. WEIGAO Company Information Table 86. WEIGAO Business Overview Table 87. WEIGAO Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 88. WEIGAO Recombinant Human BMP-2 Product Portfolio Table 89. WEIGAO Recent Development Table 90. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information Table 91. Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview Table 92. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 93. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Product Portfolio Table 94. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Development Table 95. Shanghai NovoPro Company Information Table 96. Shanghai NovoPro Business Overview Table 97. Shanghai NovoPro Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 98. Shanghai NovoPro Recombinant Human BMP-2 Product Portfolio Table 99. Shanghai NovoPro Recent Development Table 100. HANGZHOU JIUYUAN GENE ENGINEERIN Company Information Table 101. HANGZHOU JIUYUAN GENE ENGINEERIN Business Overview Table 102. HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 103. HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Product Portfolio Table 104. HANGZHOU JIUYUAN GENE ENGINEERIN Recent Development Table 105. Beijing Baiaolaibo Technology Company Information Table 106. Beijing Baiaolaibo Technology Business Overview Table 107. Beijing Baiaolaibo Technology Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 108. Beijing Baiaolaibo Technology Recombinant Human BMP-2 Product Portfolio Table 109. Beijing Baiaolaibo Technology Recent Development Table 110. STEMCELL Technologies Company Information Table 111. STEMCELL Technologies Business Overview Table 112. STEMCELL Technologies Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 113. STEMCELL Technologies Recombinant Human BMP-2 Product Portfolio Table 114. STEMCELL Technologies Recent Development Table 115. Sigma Aldrich Company Information Table 116. Sigma Aldrich Business Overview Table 117. Sigma Aldrich Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 118. Sigma Aldrich Recombinant Human BMP-2 Product Portfolio Table 119. Sigma Aldrich Recent Development Table 120. Proteintech Company Information Table 121. Proteintech Business Overview Table 122. Proteintech Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 123. Proteintech Recombinant Human BMP-2 Product Portfolio Table 124. Proteintech Recent Development Table 125. CUSABIO TECHNOLOGY Company Information Table 126. CUSABIO TECHNOLOGY Business Overview Table 127. CUSABIO TECHNOLOGY Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 128. CUSABIO TECHNOLOGY Recombinant Human BMP-2 Product Portfolio Table 129. CUSABIO TECHNOLOGY Recent Development Table 130. Cgbio Company Information Table 131. Cgbio Business Overview Table 132. Cgbio Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 133. Cgbio Recombinant Human BMP-2 Product Portfolio Table 134. Cgbio Recent Development Table 135. Cell Guidance Systems Company Information Table 136. Cell Guidance Systems Business Overview Table 137. Cell Guidance Systems Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 138. Cell Guidance Systems Recombinant Human BMP-2 Product Portfolio Table 139. Cell Guidance Systems Recent Development Table 140. Biomol GmbH Company Information Table 141. Biomol GmbH Business Overview Table 142. Biomol GmbH Recombinant Human BMP-2 Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 143. Biomol GmbH Recombinant Human BMP-2 Product Portfolio Table 144. Biomol GmbH Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Recombinant Human BMP-2 Distributors List Table 148. Recombinant Human BMP-2 Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Recombinant Human BMP-2 Product Image Figure 2. Global Recombinant Human BMP-2 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human BMP-2 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human BMP-2 Sales (2021-2032) & (Kg) Figure 5. Global Recombinant Human BMP-2 Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Recombinant Human BMP-2 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Powder Image Figure 10. Sponge Image Figure 11. Others Image Figure 12. Global Recombinant Human BMP-2 Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 13. Global Recombinant Human BMP-2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Recombinant Human BMP-2 Sales Volume Share by Type (2021-2032) Figure 15. Global Recombinant Human BMP-2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Recombinant Human BMP-2 Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Recombinant Human BMP-2 Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Research Institute Image Figure 20. Others Image Figure 21. Global Recombinant Human BMP-2 Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Recombinant Human BMP-2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Recombinant Human BMP-2 Sales Volume Share by Application (2021-2032) Figure 24. Global Recombinant Human BMP-2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Recombinant Human BMP-2 Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Recombinant Human BMP-2 Sales Value Share by Application (2021-2032) Figure 27. Global Recombinant Human BMP-2 Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global Recombinant Human BMP-2 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Recombinant Human BMP-2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Recombinant Human BMP-2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Recombinant Human BMP-2 Sales Value (2021-2032) & (US$ Million) Figure 32. North America Recombinant Human BMP-2 Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Recombinant Human BMP-2 Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Recombinant Human BMP-2 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Recombinant Human BMP-2 Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Recombinant Human BMP-2 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Recombinant Human BMP-2 Sales Value (2021-2032) & (US$ Million) Figure 38. South America Recombinant Human BMP-2 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Recombinant Human BMP-2 Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Recombinant Human BMP-2 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Recombinant Human BMP-2 Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Recombinant Human BMP-2 Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Sponge
  • Others
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • 赛默飞世尔
  • Yeasen Biotechnology (Shanghai)
  • Yantai Zhenghai Bio-Tech
  • Abbkine Scientific
  • WEIGAO
  • Shanghai Zhong Qiao Xin Zhou Biotechnology
  • Shanghai NovoPro
  • HANGZHOU JIUYUAN GENE ENGINEERIN
  • Beijing Baiaolaibo Technology
  • STEMCELL Technologies
  • Sigma Aldrich
  • Proteintech
  • CUSABIO TECHNOLOGY
  • Cgbio
  • Cell Guidance Systems
  • Biomol GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Human BMP-2 Sales Value (2021-2032)
  4. 1.2.2 Global Recombinant Human BMP-2 Sales Volume (2021-2032)
  5. 1.2.3 Global Recombinant Human BMP-2 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Recombinant Human BMP-2 Market Dynamics
  1. 2.1 Recombinant Human BMP-2 Industry Trends
  2. 2.2 Recombinant Human BMP-2 Industry Drivers
  3. 2.3 Recombinant Human BMP-2 Industry Opportunities and Challenges
  4. 2.4 Recombinant Human BMP-2 Industry Restraints
3 Recombinant Human BMP-2 Market by Company
  1. 3.1 Global Recombinant Human BMP-2 Company Revenue Ranking in 2025
  2. 3.2 Global Recombinant Human BMP-2 Revenue by Company (2021-2026)
  3. 3.3 Global Recombinant Human BMP-2 Sales Volume by Company (2021-2026)
  4. 3.4 Global Recombinant Human BMP-2 Average Price by Company (2021-2026)
  5. 3.5 Global Recombinant Human BMP-2 Company Ranking (2024-2026)
  6. 3.6 Global Recombinant Human BMP-2 Company Manufacturing Base and Headquarters
  7. 3.7 Global Recombinant Human BMP-2 Company Product Type and Application
  8. 3.8 Global Recombinant Human BMP-2 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Recombinant Human BMP-2 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Recombinant Human BMP-2 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Recombinant Human BMP-2 Market by Type
  1. 4.1 Recombinant Human BMP-2 Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Sponge
  4. 4.1.3 Others
  5. 4.2 Global Recombinant Human BMP-2 Sales Volume by Type
  6. 4.2.1 Global Recombinant Human BMP-2 Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Recombinant Human BMP-2 Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Recombinant Human BMP-2 Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Recombinant Human BMP-2 Sales Value by Type
  10. 4.3.1 Global Recombinant Human BMP-2 Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Recombinant Human BMP-2 Sales Value by Type (2021-2032)
  12. 4.3.3 Global Recombinant Human BMP-2 Sales Value Share by Type (2021-2032)
5 Recombinant Human BMP-2 Market by Application
  1. 5.1 Recombinant Human BMP-2 Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Research Institute
  4. 5.1.3 Others
  5. 5.2 Global Recombinant Human BMP-2 Sales Volume by Application
  6. 5.2.1 Global Recombinant Human BMP-2 Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Human BMP-2 Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Recombinant Human BMP-2 Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Recombinant Human BMP-2 Sales Value by Application
  10. 5.3.1 Global Recombinant Human BMP-2 Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Recombinant Human BMP-2 Sales Value by Application (2021-2032)
  12. 5.3.3 Global Recombinant Human BMP-2 Sales Value Share by Application (2021-2032)
6 Recombinant Human BMP-2 Regional Sales and Value Analysis
  1. 6.1 Global Recombinant Human BMP-2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Human BMP-2 Sales by Region (2021-2032)
  3. 6.2.1 Global Recombinant Human BMP-2 Sales by Region: 2021-2026
  4. 6.2.2 Global Recombinant Human BMP-2 Sales by Region (2027-2032)
  5. 6.3 Global Recombinant Human BMP-2 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Recombinant Human BMP-2 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Recombinant Human BMP-2 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Recombinant Human BMP-2 Sales Value by Region (2027-2032)
  9. 6.5 Global Recombinant Human BMP-2 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Recombinant Human BMP-2 Sales Value (2021-2032)
  12. 6.6.2 North America Recombinant Human BMP-2 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Recombinant Human BMP-2 Sales Value (2021-2032)
  15. 6.7.2 Europe Recombinant Human BMP-2 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Recombinant Human BMP-2 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Recombinant Human BMP-2 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Recombinant Human BMP-2 Sales Value (2021-2032)
  21. 6.9.2 South America Recombinant Human BMP-2 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Recombinant Human BMP-2 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Recombinant Human BMP-2 Sales Value Share by Country, 2025 VS 2032
7 Recombinant Human BMP-2 Country-level Sales and Value Analysis
  1. 7.1 Global Recombinant Human BMP-2 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Recombinant Human BMP-2 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Recombinant Human BMP-2 Sales by Country (2021-2032)
  4. 7.3.1 Global Recombinant Human BMP-2 Sales by Country (2021-2026)
  5. 7.3.2 Global Recombinant Human BMP-2 Sales by Country (2027-2032)
  6. 7.4 Global Recombinant Human BMP-2 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Recombinant Human BMP-2 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Recombinant Human BMP-2 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Recombinant Human BMP-2 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Recombinant Human BMP-2 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Recombinant Human BMP-2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 赛默飞世尔
  2. 8.1.1 赛默飞世尔 Company Information
  3. 8.1.2 赛默飞世尔 Business Overview
  4. 8.1.3 赛默飞世尔 Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 赛默飞世尔 Recombinant Human BMP-2 Product Portfolio
  6. 8.1.5 赛默飞世尔 Recent Developments
  7. 8.2 Yeasen Biotechnology (Shanghai)
  8. 8.2.1 Yeasen Biotechnology (Shanghai) Company Information
  9. 8.2.2 Yeasen Biotechnology (Shanghai) Business Overview
  10. 8.2.3 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yeasen Biotechnology (Shanghai) Recombinant Human BMP-2 Product Portfolio
  12. 8.2.5 Yeasen Biotechnology (Shanghai) Recent Developments
  13. 8.3 Yantai Zhenghai Bio-Tech
  14. 8.3.1 Yantai Zhenghai Bio-Tech Company Information
  15. 8.3.2 Yantai Zhenghai Bio-Tech Business Overview
  16. 8.3.3 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yantai Zhenghai Bio-Tech Recombinant Human BMP-2 Product Portfolio
  18. 8.3.5 Yantai Zhenghai Bio-Tech Recent Developments
  19. 8.4 Abbkine Scientific
  20. 8.4.1 Abbkine Scientific Company Information
  21. 8.4.2 Abbkine Scientific Business Overview
  22. 8.4.3 Abbkine Scientific Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Abbkine Scientific Recombinant Human BMP-2 Product Portfolio
  24. 8.4.5 Abbkine Scientific Recent Developments
  25. 8.5 WEIGAO
  26. 8.5.1 WEIGAO Company Information
  27. 8.5.2 WEIGAO Business Overview
  28. 8.5.3 WEIGAO Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 WEIGAO Recombinant Human BMP-2 Product Portfolio
  30. 8.5.5 WEIGAO Recent Developments
  31. 8.6 Shanghai Zhong Qiao Xin Zhou Biotechnology
  32. 8.6.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
  33. 8.6.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
  34. 8.6.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human BMP-2 Product Portfolio
  36. 8.6.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments
  37. 8.7 Shanghai NovoPro
  38. 8.7.1 Shanghai NovoPro Company Information
  39. 8.7.2 Shanghai NovoPro Business Overview
  40. 8.7.3 Shanghai NovoPro Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai NovoPro Recombinant Human BMP-2 Product Portfolio
  42. 8.7.5 Shanghai NovoPro Recent Developments
  43. 8.8 HANGZHOU JIUYUAN GENE ENGINEERIN
  44. 8.8.1 HANGZHOU JIUYUAN GENE ENGINEERIN Company Information
  45. 8.8.2 HANGZHOU JIUYUAN GENE ENGINEERIN Business Overview
  46. 8.8.3 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 HANGZHOU JIUYUAN GENE ENGINEERIN Recombinant Human BMP-2 Product Portfolio
  48. 8.8.5 HANGZHOU JIUYUAN GENE ENGINEERIN Recent Developments
  49. 8.9 Beijing Baiaolaibo Technology
  50. 8.9.1 Beijing Baiaolaibo Technology Company Information
  51. 8.9.2 Beijing Baiaolaibo Technology Business Overview
  52. 8.9.3 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Baiaolaibo Technology Recombinant Human BMP-2 Product Portfolio
  54. 8.9.5 Beijing Baiaolaibo Technology Recent Developments
  55. 8.10 STEMCELL Technologies
  56. 8.10.1 STEMCELL Technologies Company Information
  57. 8.10.2 STEMCELL Technologies Business Overview
  58. 8.10.3 STEMCELL Technologies Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 STEMCELL Technologies Recombinant Human BMP-2 Product Portfolio
  60. 8.10.5 STEMCELL Technologies Recent Developments
  61. 8.11 Sigma Aldrich
  62. 8.11.1 Sigma Aldrich Company Information
  63. 8.11.2 Sigma Aldrich Business Overview
  64. 8.11.3 Sigma Aldrich Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sigma Aldrich Recombinant Human BMP-2 Product Portfolio
  66. 8.11.5 Sigma Aldrich Recent Developments
  67. 8.12 Proteintech
  68. 8.12.1 Proteintech Company Information
  69. 8.12.2 Proteintech Business Overview
  70. 8.12.3 Proteintech Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Proteintech Recombinant Human BMP-2 Product Portfolio
  72. 8.12.5 Proteintech Recent Developments
  73. 8.13 CUSABIO TECHNOLOGY
  74. 8.13.1 CUSABIO TECHNOLOGY Company Information
  75. 8.13.2 CUSABIO TECHNOLOGY Business Overview
  76. 8.13.3 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CUSABIO TECHNOLOGY Recombinant Human BMP-2 Product Portfolio
  78. 8.13.5 CUSABIO TECHNOLOGY Recent Developments
  79. 8.14 Cgbio
  80. 8.14.1 Cgbio Company Information
  81. 8.14.2 Cgbio Business Overview
  82. 8.14.3 Cgbio Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Cgbio Recombinant Human BMP-2 Product Portfolio
  84. 8.14.5 Cgbio Recent Developments
  85. 8.15 Cell Guidance Systems
  86. 8.15.1 Cell Guidance Systems Company Information
  87. 8.15.2 Cell Guidance Systems Business Overview
  88. 8.15.3 Cell Guidance Systems Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Cell Guidance Systems Recombinant Human BMP-2 Product Portfolio
  90. 8.15.5 Cell Guidance Systems Recent Developments
  91. 8.16 Biomol GmbH
  92. 8.16.1 Biomol GmbH Company Information
  93. 8.16.2 Biomol GmbH Business Overview
  94. 8.16.3 Biomol GmbH Recombinant Human BMP-2 Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Biomol GmbH Recombinant Human BMP-2 Product Portfolio
  96. 8.16.5 Biomol GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Recombinant Human BMP-2 Value Chain Analysis
  2. 9.1.1 Recombinant Human BMP-2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Recombinant Human BMP-2 Sales Mode & Process
  6. 9.2 Recombinant Human BMP-2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Recombinant Human BMP-2 Distributors
  9. 9.2.3 Recombinant Human BMP-2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst